<- Go Home
Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Market Cap
$17.6M
Volume
470.1K
Cash and Equivalents
$4.4M
EBITDA
-$13.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$8.0M
Profit Margin
55.91%
52 Week High
$7.95
52 Week Low
$1.98
Dividend
N/A
Price / Book Value
3.74
Price / Earnings
-1.32
Price / Tangible Book Value
-2.81
Enterprise Value
$24.7M
Enterprise Value / EBITDA
-1.91
Operating Income
-$14.2M
Return on Equity
262.05%
Return on Assets
-42.48
Cash and Short Term Investments
$4.4M
Debt
$11.6M
Equity
$4.6M
Revenue
$14.4M
Unlevered FCF
-$10.5M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium